FDA approves ‘gamechanger’ weight-loss drug
By Nancy Clanton, The Atlanta Journal-Constitution Troy Warren for CNT The U.S. Food and Drug Administration approved the first new drug for chronic weight management since 2014. Wegovy (semaglutide) is a weekly injection for chronic weight management in adults who are overweight or obese with at least one weight-related condition, such as high blood pressure, Type 2 diabetes or high cholesterol. It is for use in addition to a reduced-calorie diet and increased physical activity. The FDA’s June 4 approval “offers adults with obesity or [who are] overweight a beneficial new treatment option to incorporate into a weight management program,” said John Sharretts,…